ERLOTINIB HYDROCHLORIDE
HETERO LABS LTD V · ERLOTINIB HYDROCHLORIDE
Open FDA's page for this record- Application number
- ANDA209267
- Sponsor name
- HETERO LABS LTD V
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20240524
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 002
- Reference drug
- No
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- ERLOTINIB HYDROCHLORIDE
- Strength
- EQ 100MG BASE
- Product number
- 003
- Reference drug
- No
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- ERLOTINIB HYDROCHLORIDE
- Strength
- EQ 150MG BASE
- Product number
- 001
- Reference drug
- No
- Brand name
- ERLOTINIB HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- ERLOTINIB HYDROCHLORIDE
- Strength
- EQ 25MG BASE
- Harmonized identifiers (openFDA)
- Application number
- ANDA209267
- Brand name
- ERLOTINIB
- Generic name
- ERLOTINIB
- Manufacturer name
- Camber Pharmaceuticals, Inc.
- Product NDC
- 31722-263, 31722-264, 31722-265
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- ERLOTINIB HYDROCHLORIDE
- RxCUI
- 603203, 603206, 603208
- SPL ID
- 1bca3db4-f885-5bed-e063-6294a90ae9fa
- SPL set ID
- a3b2d622-b4d5-4819-862b-f8fd3adcec6f
- Package NDC
- 31722-263-30, 31722-264-30, 31722-265-30
- UNII
- DA87705X9K
